TR201000619A2 - Pharmaceutical composition in dry powder form comprising tiotropium and mometasone. - Google Patents
Pharmaceutical composition in dry powder form comprising tiotropium and mometasone.Info
- Publication number
- TR201000619A2 TR201000619A2 TR2010/00619A TR201000619A TR201000619A2 TR 201000619 A2 TR201000619 A2 TR 201000619A2 TR 2010/00619 A TR2010/00619 A TR 2010/00619A TR 201000619 A TR201000619 A TR 201000619A TR 201000619 A2 TR201000619 A2 TR 201000619A2
- Authority
- TR
- Turkey
- Prior art keywords
- tiotropium
- mometasone
- dry powder
- powder form
- pharmaceutical composition
- Prior art date
Links
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 title abstract 2
- 229960001664 mometasone Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000000843 powder Substances 0.000 title abstract 2
- LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical compound O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 title abstract 2
- 229940110309 tiotropium Drugs 0.000 title abstract 2
- 239000002775 capsule Substances 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Mevcut buluş, solunum yolu rahatsızlıklarında kullanılmak üzere, tiotropium ve mometazon ve/veya bunların farmasötik olarak kabul edilebilir türevlerinin kombinasyonlarını kapsayan kuru toz formundaki farmasötik kompozisyonlara ve bunları içeren kapsül formlarına ilişkindir.The present invention relates to pharmaceutical compositions in dry powder form comprising combinations of tiotropium and mometasone and / or pharmaceutically acceptable derivatives thereof for use in respiratory disorders and capsule forms containing them.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2010/00619A TR201000619A2 (en) | 2010-01-28 | 2010-01-28 | Pharmaceutical composition in dry powder form comprising tiotropium and mometasone. |
| PCT/TR2011/000012 WO2011093810A2 (en) | 2010-01-28 | 2011-01-28 | Dry powder pharmaceutical composition comprising tiotropium and mometasone |
| US13/531,972 US8834931B2 (en) | 2009-12-25 | 2012-06-25 | Dry powder formulation containing tiotropium for inhalation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2010/00619A TR201000619A2 (en) | 2010-01-28 | 2010-01-28 | Pharmaceutical composition in dry powder form comprising tiotropium and mometasone. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201000619A2 true TR201000619A2 (en) | 2011-08-22 |
Family
ID=44950380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2010/00619A TR201000619A2 (en) | 2009-12-25 | 2010-01-28 | Pharmaceutical composition in dry powder form comprising tiotropium and mometasone. |
Country Status (1)
| Country | Link |
|---|---|
| TR (1) | TR201000619A2 (en) |
-
2010
- 2010-01-28 TR TR2010/00619A patent/TR201000619A2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE060743T2 (en) | Pharmaceutical compositions containing imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (PAR4) inhibitors for the treatment of platelet aggregation | |
| EA201390049A1 (en) | DRY POWDER PREPARATION CONTAINING PHOSPHODESTERASE INHIBITOR | |
| MX2013001677A (en) | Stable formulations of linaclotide. | |
| IL223795A (en) | Tetrahydro-pyrido-pyrimidine derivatives, process for their preparation, pharmaceutical compositions comprising them and use thereof in the manufacture of medicaments | |
| EA201291306A1 (en) | COMPOSITION OF DRY POWDER CONTAINING ANTIMUSCARINE MEANS | |
| TR201000680A2 (en) | Pharmaceutical compositions containing tiotropium, formoterol and budesonide | |
| TR201000681A2 (en) | Dry powder formulations inhaled. | |
| HUE040525T2 (en) | Dry powder composition containing corticosteroid and beta-adrenergic agent for administration by inhalation | |
| BR112015027017A2 (en) | inhalable pharmaceutical compositions and inhaler devices containing the same | |
| TR201000733A2 (en) | Pharmaceutical compositions comprising fluticasone, tiotropium and sodium chromoglycate. | |
| MX2016001422A (en) | Pharmaceutical compositions of fingolimod. | |
| MX2015009891A (en) | Pharmaceutical compositions comprising multi-component crystalline particles suitable for use in inhalation therapy. | |
| WO2011093815A3 (en) | Pharmaceutical compositions comprising formoterol and mometasone | |
| WO2011093818A3 (en) | Pharmaceutical compositions comprising salmeterol and fluticasone | |
| EA201500446A1 (en) | PHARMACEUTICAL COMPOSITION TO REDUCE N-OXIDE TRIMETYLAMINE LEVEL | |
| WO2011093811A3 (en) | Pharmaceutical preparations comprising formoterol and fluticasone | |
| TR200907913A2 (en) | Pharmaceutical composition in dry powder form for inhalation | |
| TR201000619A2 (en) | Pharmaceutical composition in dry powder form comprising tiotropium and mometasone. | |
| TR201000621A2 (en) | Pharmaceutical composition in dry powder form containing tiotropium and budesonide | |
| TR201000624A2 (en) | Pharmaceutical composition in dry powder form comprising tiotropium and fluticasone. | |
| TR201000730A2 (en) | Pharmaceutical composition in dry powder form comprising tiotropium and mometasone. | |
| TR201000620A2 (en) | Pharmaceutical composition in dry powder form comprising tiotropium and ciclesonide. | |
| TR200907914A2 (en) | Pharmaceutical composition in the form of a dry powder containing corticosteroid. | |
| WO2011093812A3 (en) | Pharmaceutical formulation comprising tiotropium and budesonide in dry powder form | |
| TR201000731A2 (en) | Pharmaceutical composition in dry powder form comprising tiotropium and fluticasone. |